Cargando…

A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone

SUMMARY: We encountered a case of childhood-onset lymphocytic infundibuloneurohypophysitis, based on the MRI and endocrinological findings, with decreased function of the anterior and posterior lobes of the pituitary. Three years after the diagnosis, the patient developed non-alcoholic steatohepatit...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Hidekuni, Nishimata, Shigeo, Kumada, Atsushi, Yamanaka, Gaku, Kashiwagi, Yasuyo, Kawashima, Hisashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002206/
https://www.ncbi.nlm.nih.gov/pubmed/35319489
http://dx.doi.org/10.1530/EDM-21-0148
_version_ 1784685842412863488
author Takahashi, Hidekuni
Nishimata, Shigeo
Kumada, Atsushi
Yamanaka, Gaku
Kashiwagi, Yasuyo
Kawashima, Hisashi
author_facet Takahashi, Hidekuni
Nishimata, Shigeo
Kumada, Atsushi
Yamanaka, Gaku
Kashiwagi, Yasuyo
Kawashima, Hisashi
author_sort Takahashi, Hidekuni
collection PubMed
description SUMMARY: We encountered a case of childhood-onset lymphocytic infundibuloneurohypophysitis, based on the MRI and endocrinological findings, with decreased function of the anterior and posterior lobes of the pituitary. Three years after the diagnosis, the patient developed non-alcoholic steatohepatitis (NASH), which was effectively treated by growth hormone (GH) supplementation. The present case demonstrated that NASH can be effectively treated by short-term GH supplementation, even in late childhood. LEARNING POINTS: In recent years, the efficacy of growth hormone replacement therapy in normalizing the liver function of adult-onset growth hormone deficiency patients with non-alcoholic steatohepatitis (NASH) has been reported. Lymphocytic infundibuloneurohypophysitis is a very rare disease, particularly in childhood. We here presented a rare case of a child with lymphocytic infundibuloneurohypophysitis who developed NASH and showed substantial improvement in liver function after growth hormone treatment.
format Online
Article
Text
id pubmed-9002206
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-90022062022-04-12 A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone Takahashi, Hidekuni Nishimata, Shigeo Kumada, Atsushi Yamanaka, Gaku Kashiwagi, Yasuyo Kawashima, Hisashi Endocrinol Diabetes Metab Case Rep Novel Treatment SUMMARY: We encountered a case of childhood-onset lymphocytic infundibuloneurohypophysitis, based on the MRI and endocrinological findings, with decreased function of the anterior and posterior lobes of the pituitary. Three years after the diagnosis, the patient developed non-alcoholic steatohepatitis (NASH), which was effectively treated by growth hormone (GH) supplementation. The present case demonstrated that NASH can be effectively treated by short-term GH supplementation, even in late childhood. LEARNING POINTS: In recent years, the efficacy of growth hormone replacement therapy in normalizing the liver function of adult-onset growth hormone deficiency patients with non-alcoholic steatohepatitis (NASH) has been reported. Lymphocytic infundibuloneurohypophysitis is a very rare disease, particularly in childhood. We here presented a rare case of a child with lymphocytic infundibuloneurohypophysitis who developed NASH and showed substantial improvement in liver function after growth hormone treatment. Bioscientifica Ltd 2022-02-21 /pmc/articles/PMC9002206/ /pubmed/35319489 http://dx.doi.org/10.1530/EDM-21-0148 Text en © The authors https://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Novel Treatment
Takahashi, Hidekuni
Nishimata, Shigeo
Kumada, Atsushi
Yamanaka, Gaku
Kashiwagi, Yasuyo
Kawashima, Hisashi
A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone
title A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone
title_full A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone
title_fullStr A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone
title_full_unstemmed A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone
title_short A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone
title_sort 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone
topic Novel Treatment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002206/
https://www.ncbi.nlm.nih.gov/pubmed/35319489
http://dx.doi.org/10.1530/EDM-21-0148
work_keys_str_mv AT takahashihidekuni a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone
AT nishimatashigeo a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone
AT kumadaatsushi a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone
AT yamanakagaku a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone
AT kashiwagiyasuyo a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone
AT kawashimahisashi a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone
AT takahashihidekuni 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone
AT nishimatashigeo 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone
AT kumadaatsushi 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone
AT yamanakagaku 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone
AT kashiwagiyasuyo 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone
AT kawashimahisashi 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone